| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.0007 |